Comorbidity and the Treatment of Principal Anxiety Disorders in a Naturalistic Sample

Behavior Therapy

Volumn 41, Issue 3, 2010, Pages 296-305

  Davis, Lissa ^a   Barlow, David H ^a   Smith, Lisa ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL FEATURE; COGNITIVE THERAPY; COMORBIDITY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; TREATMENT DURATION; TREATMENT RESPONSE; ADOLESCENT; AGED; ANXIETY DISORDERS; DEPRESSIVE DISORDER; MIDDLE AGED; PATIENT DROPOUTS; PROGNOSIS; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; SELF EVALUATION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANXIETY DISORDERS; COGNITIVE THERAPY; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT DROPOUTS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SELF ASSESSMENT (PSYCHOLOGY); SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT; SELF-ASSESSMENT;

EID: 77953614497     PISSN: 00057894     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beth.2009.09.002     Document Type: Article

References (37)

1. Abramovitz J.S., Foa E.B. Does comorbid major depressive disorder influence outcome or exposure and response prevention for OCD?. Behavior Therapy 2000, 31:795-800.
2. Allen L.B., McHugh R.K., Barlow D.H. Emotional disorders: A unified protocol. Clinical handbook of psychological disorders 2008, Guilford Press, New York. 4th ed. D.H. Barlow (Ed.).
3. Allen, L. B., White, K. S., Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. (2007). Comorbidity as a moderator and outcome measure in patients receiving cognitive-behavioral treatment for panic disorder. Manuscript submitted for publication.
4. Barlow D.H., Allen L.B., Choate M.L. Towards a unified treatment for emotional disorders. Behavior Therapy 2004, 35:205-230.
5. Beck A.T., Steer R.A. Manual for the revised Beck Depression Inventory 1987, Psychological Corporation, San Antonio, TX.
6. Beck A.T., Steer R.A., Brown G.K. Manual for the Beck Depression Inventory II (BDI-II) 1996, Psychological Corporation, San Antonio, TX.
7. Belzer K., Schneier F.R. Comorbidity of anxiety and depressive disorders: Issues in conceptualization, assessment, and treatment. Journal of Psychiatric Practice 2004, 10:296-306.
8. Borkovec T.D., Abel J.L., Newman H. Effects of psychotherapy on comorbid conditions in generalized anxiety disorder. Journal of Consulting and Clinical Psychology 1995, 63:479-483.
9. Brown C., Schulberg H.C., Madonia M.J., Shear M.K., Houck P.R. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. American Journal of Psychiatry 1996, 153:1293-1300.
10. Brown T.A., Antony M.M., Barlow D.H. Diagnostic comorbidity in panic disorder: Effect on treatment outcome and course of comorbid diagnoses following treatment. Journal of Consulting and Clinical Psychology 1995, 63:408-418.
11. Brown T.A., Barlow D.H. Comorbidity among anxiety disorders: Implications for treatment and DSM-IV. Journal of Consulting and Clinical Psychology 1992, 60:835-844.
12. Brown T.A., Barlow D.H. Long-term outcome in cognitive-behavioral treatment of panic disorder: Clinical predictors and alternative strategies for assessment. Journal of Consulting and Clinical Psychology 1995, 63:754-765.
13. Brown T.A., Di Nardo P.A., Lehman C.L., Campbell L.A. Reliability of DSM-IV anxiety and mood disorders: Implications for the classification of emotional disorders. Journal of Abnormal Psychology 2001, 110:49-58.
14. Chambless D.L., Tran G.Q., Glass C.R. Predictors of response to cognitive-behavioral group therapy for social phobia. Journal of Anxiety Disorders 1997, 11:221-240.
15. Di Nardo P.A., Barlow D.H. Syndrome and symptom comorbidity in the anxiety disorders. Comorbidity in anxiety and mood disorders 1990, 205-230. American Psychiatric Press, Washington, DC. J.D. Maser, C.R. Cloninger (Eds.).
16. Di Nardo P.A., Brown T.A., Barlow D.H. Anxiety Disorders Interview Schedule for DSM-IV Lifetime Version 1994, Oxford University Press, New York.
17. Emmanuel J., Simmonds S., Tyrer P. Systematic review of the outcome of anxiety and depressive disorders. British Journal of Psychiatry 1998, 34(Suppl.):35-41.
18. Erwin B.A., Heimberg R.G., Juster H., Mindlin M. Comorbid anxiety and mood disorders among persons with social anxiety disorder. Behaviour Research and Therapy 2002, 41:19-35.
19. Feinstein A.R. The pretherapeutic classification of co-morbidity in chronic disease. Journal of Chronic Disease 1970, 23:455-468.
20. Goisman R.M., Goldenberg I., Vasile R.G., Keller M.B. Comorbidity of anxiety disorders in a multicenter anxiety study. Comprehensive Psychiatry 1995, 36:303-311.
21. Goldenberg I.M., White K., Yonkers K., Reich J., Warshaw M.G., Goisman R.M., et al. The infrequency of "pure culture" diagnoses among the anxiety disorders. Journal of Clinical Psychiatry 1996, 57:528-533.
22. Hafner J., Marks I.M. Exposure in vivo of agoraphobics: Contributions of diazepam, group exposure, and anxiety evocation. Psychological Medicine 1976, 6:71-88.
23. Lovibond S.H., Lovibond P.F. Manual for the Depression Anxiety Stress Scales 1995, Sydney, Psychology Foundation. 2nd ed.
24. Mataix-Cols D., Cowley A.J., Hankins M., Schneider A., Bachofen M., Kenwright M., et al. Reliability and validity of the Work and Social Adjustment Scale in phobic disorders. Comprehensive Psychiatry 2004, 46:223-228.
25. McLean P.D., Woody S., Taylor S., Koch W.J. Comorbid panic disorder and major depression: Implications for cognitive-behavioral therapy. Journal of Consulting and Clinical Psychology 1998, 66:240-247.
26. Mennin D.S., Heimberg R.G., Jack M.S. Comorbid generalized anxiety disorder in primary social phobia: Symptom severity, functional impairment, and treatment response. Journal of Anxiety Disorders 2000, 14:325-343.
27. Mineka S., Watson D., Clark L.A. Comorbidity of anxiety and unipolar mood disorders. Annual Review of Psychology 1998, 49:377-412.
28. Moscovitch D.A., Hofmann S.G., Suvak M.A., In-Albon T. Mediation of changes in anxiety and depression during treatment of social phobia. Journal of Consulting and Clinical Psychology 2005, 73:945-952.
29. Mundt J.C., Marks I.M., Shear M.K., Greist J.H. The Work and Social Adjustment Scale (WSAS): A simple accurate measure of impairment in functioning. British Journal of Psychiatry 2002, 180:461-464.
30. Norton P.J., Hayes S.A., Hope D.A. Effects of a transdiagnostic group treatment for anxiety on secondary depression. Depression and Anxiety 2004, 20:198-202.
31. Nutt D., Argyopoulos S., Hood S., Potokar J. Generalized anxiety disorder: A comorbid disease. European Neuropsychopharmacology 2006, 16(S2):S109-18.
32. Pincus H.A., Tew J.D., First M.B. Psychiatric comorbidity: Is more less?. World Psychiatry 2004, 3:18-23.
33. Sanderson W.C., Di Nardo P.A., Rapee R.M., Barlow D.H. Syndrome comorbidity in patients diagnosed with a DSM-III-R anxiety disorder. Journal of Abnormal Psychology 1990, 99:308-312.
34. Steketee G., Chambless D.L., Tran G.Q. Effects of Axis I and II comorbidity on behavior therapy outcome for obsessive-compulsive disorder and agoraphobia. Comprehensive Psychiatry 2001, 42:76-86.
35. Tsao J.C.I., Lewin M.R., Craske M.G. The effects of cognitive-behavior therapy for panic disorder on comorbid conditions. Journal of Anxiety Disorders 1998, 12:357-371.
36. Tsao J.C.I., Mystkowski J.L., Zucker B.G., Craske M.G. Effects of cognitive-behavior therapy for panic disorder on comorbid conditions: Replication and extension. Behavior Therapy 2002, 33:493-509.
37. Tsao J.C.I., Mystkowski J.L., Zucker B.G., Craske M.G. Impact of cognitive-behavioral therapy for panic disorder on comorbidity: A controlled investigation. Behaviour Research and Therapy 2005, 43:959-970.